Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
BBC News - Tuesday, 10 September, 2002
The annual conference of the Public Health Laboratory Service heard that the growing problem of resistance made measures to prevent initial HIV infection ever more important.
Dr Deenan Pillay, of the PHLS Antiviral Susceptibility Reference Unit in Birmingham, told the conference that experts had long suspected HIV patients might begin to develop resistance to drugs after they had been receiving treatment for some time.
"However we now know that resistant strains can be transmitted from one person to another, meaning that patients can be carrying drug-resistant strains from the moment they are infected," he said.
"This does not mean that they cannot be treated, but it does mean that the range of drugs available to treat them is reduced."
On-going problem
Dr Pillay said that resistance, once established, appeared, in most cases, to remain.
Among five patients who had been infected with resistant HIV, in four of them the resistant element persisted for up to three years.
He said: "Although this is a small study, it further highlights the potentially serious impact of HIV resistance."
Dr Pillay said the development of new drugs was vital as nobody knew how long existing therapies would be able to keep HIV in check.
But he added: "HIV is an entirely preventable disease and now more than ever we need to ensure that the prevention messages are heeded.
"Safer sex is the key to preventing HIV."
Herpes
Another study presented at the conference has found that among HIV patients in south London there were high levels of Herpes simplex virus 2, which puts them at increased risk of transmitting HIV.
The study found that among 800 HIV patients in south London, 71% were infected with HSV-2.
Dr Anna Maria Geretti, of the PHLS in south London said: "We already know that if a patient with HIV is also infected with HSV-2, the virus which causes genital herpes, they are at increased risk of transmitting HIV to a sexual partner even if they have no herpes symptoms.
"Doctors may wish to consider offering HIV patients the opportunity to be tested for HSV-2 so that those who are infected can be made aware of the increased risk of transmission."
020910
BB020906
Copyright © 2002 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, theElton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.